2006, Bipolar disorder and Manufacturing - Mental Health Clinicians

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2006

Bipolar disorder

Manufacturing

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

MARCH 15, 2025

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). appeared first on Mad In America.

Neurotransmitters and mental health

Neurotransmitters and mental health Trauma and the brain Manufacturing Pharmaceuticals

Medication Overload, Part II: The Explosion of Drugs for Kids

Mad in America

OCTOBER 10, 2023

Bristol Myers, along with the many other manufacturing plants located in the surrounding area, helped to grow and strengthen our local economy. By the mid-2000s, because of cheaper costs to manufacture penicillin in foreign countries, the plant downsized considerably. She was four years old.

Manufacturing

Manufacturing Pharmaceuticals Aging and mental health Nonprofits

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Medication Overload, Part II: The Explosion of Drugs for Kids

Stay Connected